Source: International Congress 2019 – Complex respiratory infections in clinical practice
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Terranova (Milan, Italy), A. Gramegna (Milan, Italy), M. Oriano (Milan, Italy), M. Pappalettera (Milan, Italy), M. Contarini (Milan, Italy), A. Colombo (Milan, Italy), F. Nava (Milan, Italy), F. Amati (Milan, Italy), A. Bellofiore (Milan, Italy), C. Marotta (Milan, Italy), P. Marchisio (Milan, Italy), S. Aliberti (Milan, Italy), F. Blasi (Milan, Italy). Respiratory viruses in adults with cystic fibrosis during stable and exacerbations. 4578

Member's Comments

No comment yet.

Related content which might interest you: Viral infections trigger exacerbations of cystic fibrosis in adults and children Source: Eur Respir J 2012; 40: 510-512 Year: 2012 Frequency and pathogenicity of rhinovirus associated pulmonary exacerbations in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Respiratory infections in cystic fibrosis Source: ERS Courses: Paediatric respiratory infections Year: 2019 Pulmonary function of infants with cystic fibrosis, with and without respiratory symptoms Source: Eur Respir J 2002; 20: Suppl. 38, 529s Year: 2002 Assessing response to treatment of exacerbations of bronchiectasis in adults Source: Eur Respir J 2009; 33: 312-318 Year: 2009 Respiratory viruses in stable state bronchiectasis Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Pathogenicity of individual rhinovirus species during exacerbations of cystic fibrosis Source: Eur Respir J 2015; 45: 1748-1751 Year: 2015 GORD/PPI and exacerbations in adults with bronchiectasis Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Palivizumab prophylaxis for respiratory syncytial virus (RSV) in infants with cystic fibrosis (CF) and respiratory illness hospitalizations Source: International Congress 2015 – Paediatric pulmonary infections Year: 2015 Respiratory viral infections in patients with exacerbation of chronic obstructive pulmonary disease and asthma in Korea Source: Eur Respir J 2005; 26: Suppl. 49, 285s Year: 2005 Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Respiratory viral infections in Iranian patients with exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Respiratory infections in paediatrics: from pneumonia to cystic fibrosis Source: Annual Congress 2007 - Infections year in review Year: 2007 Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Association between respiratory viruses and exacerbations in COPD patients Source: Annual Congress 2010 - Genetics and risk factors for asthma and COPD Year: 2010 Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016 Impact of lung disease on respiratory impedance in young children with cystic fibrosis Source: Eur Respir J 2015; 46: 1672-1679 Year: 2015 Symptom duration and the lung clearance index in children with cystic fibrosis and pulmonary exacerbations Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017